课题基金 / 基金详情

PHASE 3 COMPARISON OF LOPINAVIR/RITONAVIR EFAVIRENZ STAVUDINE LAMIVUDINE FOR INI

PHASE 3 COMPARISON OF LOPINAVIR/RITONAVIR EFAVIRENZ STAVUDINE LAMIVUDINE FOR INI
洛匹那韦/利托那韦 依非韦伦 司他夫定 拉米夫定治疗 INI 的 3 期比较
批准号:
7625534
负责人:
DAVID A WOHL
金额:
$2.75万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-11-30

项目摘要

项目成果

DAVID A WOHL的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to compare three different anti-HIV drug regimens in people who have not yet been treated for their HIV infection. The study will look at the effectiveness and safety of the three drug regimens and how well these regimens are tolerated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
Mentoring New Investigators in Criminal Justice HIV Prevention and Treatment
FAT REDISTRIBUTION AND METABOLIC CHANGE IN HIV INFECTION